MAP-00057 (MAP Pharmaceuticals)

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMAP-00057 (MAP Pharmaceuticals)
Drug Alias NameMAP-00057
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D3 receptor agonistsDopamine D2 receptor agonists
TargetsDopamine D2 receptorDopamine D3 receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMap Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMap Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A